Abstract:[Background] Pigeon adenovirus (PiAdV), pigeon circovirus (PiCV), and pigeon herpesvirus (PiHV) are major pathogens that seriously jeopardize the health of pigeon flocks and often lead to coinfections, posing challenges for clinical differential diagnosis. [Objective] To establish a triplex TaqMan fluorescent quantitative PCR (real-time quantitative PCR, RT-qPCR) method for the simultaneous detection of PiAdV, PiCV, and PiHV. [Methods] We obtained the conserved regions by searching and comparing the genomes of PiAdV, PiCV, and PiHV published in GenBank. Primers and probes were designed based on the conserved region, and plasmid standards pMD19-T-PiAdV Ⅰ, pMD19-T-PiAdV Ⅱ, pMD19-T-PiCV, and pMD19-T-PiHV were prepared. The reaction systems were optimized and the standard curves were drawn to evaluate the specificity, sensitivity, and repeatability of the established assay. A triplex TaqMan RT-qPCR assay for simultaneous detection of PiAdV, PiCV, and PiHV was thus established. It was then used to test the clinical samples, and its clinical applicability was established. [Results] The standard curves of the triple TaqMan RT-qPCR assay for PiAdV, PiCV, and PiHV were y=–3.396x+43.210 (R2=0.998 3), y=–3.540x+40.540 (R2=0.999 4), and y=–3.280x+38.470 (R2=0.998 4), respectively, showing good linear relationships. The assay showed no cross-reaction with other common pigeon pathogens such as pigeon pox virus and pigeon rotavirus, as well as fowl adenovirus type 4, showcasing strong specificity. For PiAdV, PiCV, and PiHV, the assay showed the minimum detection limits of 10 copies/μL, 10 copies/μL, and 1 copy/μL, respectively, which are 100 to 1 000 times more sensitive than the conventional PCR method, indicating high sensitivity. The coefficient of variation was less than 2.0% in both intra-batch and inter-batch repeatability tests, demonstrating good repeatability and stability. The established triple TaqMan RT-qPCR assay for PiAdV, PiCV, and PiHV was used to detect 152 pigeon clinical samples and showed slightly higher positive rates (PiAdV 55.92%, PiCV 51.32%, and PiHV 40.13%) than the conventional PCR method, demonstrating good clinical applicability. [Conclusion] The established triple TaqMan RT-qPCR assay for the detection of PiAdV, PiCV, and PiHV has good linear relationships and high specificity, sensitivity, and repeatability. It can be used for rapid, efficient, and specific detection of PiAdV, PiCV, and PiHV in clinical samples, serving as an efficient technical method for early diagnosis of the three viruses as well as for the study of synergistic pathogenic mechanism and epidemiological investigation.